Latest updates for Cscrx
Fresh curated links around CSCRX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Columbia Small Cap Growth Fund Q1 2026 Commentary
- ScanSource: Not Buying Into The Rally
- Oscar Health: Great Business In A Shrinking Market
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
fool.com
/4 weeks ago
SCHA vs. ISCB: Which Small-Cap ETF Is the Better Buy for Investors in 2026?
Sector allocations, expense ratios, and yield profiles set these two small-cap ETFs apart for investors seeking portfolio diversification.
seekingalpha.com
/1 month ago
YieldMax Short TSLA Option Income Strategy ETF announces weekly distribution of $0.1943
seekingalpha.com
/2 weeks ago
Cytosorbents Corporation (CTSO) Presents at Life Sciences Virtual Investor Forum - Slideshow
seekingalpha.com
/1 month ago
YieldMax Short TSLA Option Income Strategy ETF announces weekly distribution of $0.1943
pharmexec.com
/1 month ago
<![CDATA[Pharmaceutical Executive Daily: CVS Health to Offer Zepbound and Foundayo]]>
seekingalpha.com
/3 weeks ago
C4 Therapeutics, Inc. (CCCC) Discusses Evolving Multiple Myeloma Treatments and the Role of IKZF1/3 Degraders Including...
fool.com
/1 month ago
Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase
Corvus Pharmaceuticals develops immuno-oncology therapies, advancing clinical candidates for cancer and immune-related conditions.
seekingalpha.com
/1 month ago
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at...
fool.com
/1 week ago
Which Small Cap ETF Is the Better Buy in 2026? iShares and JPMorgan Have Compelling Offerings
ISCB offers ultra-low costs and 1,500+ holdings for diversification, while BBSC concentrates on fewer names with higher recent returns.
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Cscrx
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
fool.com
Recent coverage from public sources
Public source
pharmexec.com
Recent coverage from public sources
Public source